Ultrasound as an Outcome Measure in Gout. A Validation Process by the OMERACT Ultrasound Working Group

REFERENCES

1. 1.↵
   1. Mikuls TR,
   2. Farrar JT,
   3. Bilker WB,
   4. Fernandes S,
   5. Schumacher HR Jr,
   6. Saag KG

   . Gout epidemiology: Results from the UK General Practice Research Database, 1990–1999. Ann Rheum Dis 2005;64:267–72.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Zhu Y,
   2. Pandya BJ,
   3. Choi HK

   . Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum 2011;63:3136–41.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Hamburger M,
   2. Baraf HS,
   3. Adamson TC 3rd,
   4. Basile J,
   5. Bass L,
   6. Cole B,
   7. et al.

   2011 recommendations for the diagnosis and management of gout and hyperuricemia. Postgrad Med 2011;123:3–36.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Choi HK,
   2. Curhan G

   . Independent impact of gout on mortality and risk for coronary heart disease. Circulation 2007;116:894–900.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Krishnan E,
   2. Baker JF,
   3. Furst DE,
   4. Schumacher HR

   . Gout and the risk of acute myocardial infarction. Arthritis Rheum 2006;54:2688–96.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Sivera F,
   2. Andrès M,
   3. Falzon L,
   4. van der Heijde DM,
   5. Carmona L

   . Diagnostic value of clinical, laboratory, and imaging findings in patients with a clinical suspicion of gout: a systematic literature review. J Rheumatol Suppl 2014;92:3–8.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. De Miguel E,
   2. Puig JG,
   3. Castillo C,
   4. Peiteado D,
   5. Torres RJ,
   6. Martín-Mola E

   . Diagnosis of gout in patients with asymptomatic hyperuricaemia: a pilot ultrasound study. Ann Rheum Dis 2012;71:157–8.

   OpenUrlFREE Full Text
8. 8.↵
   1. Pineda C,
   2. Amezcua-Guerra LM,
   3. Solano C,
   4. Rodriguez-Henríquez P,
   5. Hernández-Díaz C,
   6. Vargas A,
   7. et al.

   Joint and tendon subclinical involvement suggestive of gouty arthritis in asymptomatic hyperuricemia: an ultrasound controlled study. Arthritis Res Ther 2011;13:R4.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Puig JG,
   2. de Miguel E,
   3. Castillo MC,
   4. Rocha AL,
   5. Martínez MA,
   6. Torres RJ

   . Asymptomatic hyperuricemia: impact of ultrasonography. Nucleosides Nucleotides Nucleic Acids 2008;27:592–5.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Chowalloor PV,
    2. Keen HI

    . A systematic review of ultrasonography in gout and asymptomatic hyperuricaemia. Ann Rheum Dis 2013;72:638–45.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Wakefield RJ,
    2. Gibbon WW,
    3. Conaghan PG,
    4. O’Connor P,
    5. McGonagle D,
    6. Pease C,
    7. et al.

    The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography. Arthritis Rheum 2000;43:2762–70.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Szkudlarek M,
    2. Narvestad E,
    3. Klarlund M,
    4. Court-Payen M,
    5. Thomsen HS,
    6. Østergaard M

    . Ultrasonography of the metatarsophalangeal joints in rheumatoid arthritis: comparison with magnetic resonance imaging, conventional radiography, and clinical examination. Arthritis Rheum 2004;50:2103–12.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Boers M,
    2. Kirwan JR,
    3. Wells G,
    4. Beaton D,
    5. Gossec L,
    6. d’Agostino MA,
    7. et al.

    Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0. J Clin Epidemiol 2014;67:745–53.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Gutierrez M,
    2. Schmidt WA,
    3. Thiele R,
    4. Keen H,
    5. Kaeley G,
    6. Naredo E,
    7. et al.

    International consensus for ultrasound lesions in gout. Results of Delphi process and Web-reliability exercise. Rheumatology 2015; May 13 (E-pub ahead of print).
15. 15.↵
    1. Wakefield RJ,
    2. Balint PV,
    3. Szkudlarek M,
    4. Filippucci E,
    5. Backhaus M,
    6. D’Agostino MA,
    7. et al.

    Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol 2005;32:2485–7.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Landis JR,
    2. Koch GG

    . The measurement of observer agreement for categorical data. Biometrics 1977;33:159–74.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Terslev L,
    2. Gutierrez M,
    3. Schmidt WA,
    4. Keen HI,
    5. Filippucci E,
    6. Kane D,
    7. et al.

    Ultrasound as an outcome measure in gout. A validation process by the OMERACT Ultrasound Working Group. J Rheumatol 2015;42:2177–81.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Schumacher HR,
    2. Taylor W,
    3. Edwards L,
    4. Grainger R,
    5. Schlesinger N,
    6. Dalbeth N,
    7. et al.

    Outcome domains for studies of acute and chronic gout. J Rheumatol 2009;36:2342–5.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Peiteado D,
    2. De Miguel E,
    3. Villalba A,
    4. Ordóñez MC,
    5. Castillo C,
    6. Martín-Mola E

    . Value of a short four-joint ultrasound test for gout diagnosis: a pilot study. Clin Exp Rheumatol 2012;30:830–7.

    OpenUrlPubMed
20. 20.↵
    1. Naredo E,
    2. Uson J,
    3. Jiménez-Palop M,
    4. Martínez A,
    5. Vicente E,
    6. Brito E,
    7. et al.

    Ultrasound-detected musculoskeletal urate crystal deposition: which joints and what findings should be assessed for diagnosing gout? Ann Rheum Dis 2014;73:1522–8.

    OpenUrlAbstract/FREE Full Text